II. Definitions
III. Epidemiology
- 
                          Incidence in United States
- Ages 20 to 39 years: 7.5%
 - Ages 40 to 49 years: 11%
 - Ages 50 to 59 years: 18%
 - Ages 60 to 69 years: 38%
 - Age over 70 years: 57%
 
 - Prevalence in United States: 10-20 Million
 
IV. Pathophysiology
- See Penile Anatomy and Erection physiology
 - Organic disease responsible for 80% of cases
 - Arterial or venous disease accounts for 70% of cases
 
V. Causes
VI. History
- Assess Severity of symptoms
 - Characteristics of Erectile Dysfunction
- Frequency and duration of Impotence
 - Partial or complete lack of rigidity (and absent of morning Erection)
- Vascular causes (e.g. Peripheral Vascular Disease)
 - Medication causes of Erectile Dysfunction
 - Pelvic surgery
 
 - Libido difficulties
- Hypogonadism
 - Hpothyroidism
 - Maor depression
 
 - No orgasm (anorgasmia) or decreased quality of orgasm
- Alcohol Abuse
 - Thyroid disease
 - Medication causes of Erectile Dysfunction
 - Major Depression
 - Pelvic surgery or irradiation
 
 - Decreased ejaculate volume
- Normal aging
 - Chronic Prostatitis
 - Ejaculatory duct obstruction
 - Retrograde ejaculation
 
 - Painful sexual intercourse
- Sexual abuse
 - Genital Piercings
 - Sexually Transmitted Disease (e.g. Herpes Simplex Virus Infection)
 
 
 - Symptoms suggestive of Psychogenic Impotence
 - Review potential Impotence Causes
 - Consider comorbid conditions
- Coronary Artery Disease is common in Impotence
 
 
VII. Exam
- 
                          Blood Pressure
                          
- Cardiovascular disease
 - Peripheral Vascular Disease
 
 - 
                          Heart Rate
                          
- Generalized Anxiety Disorder
 - Hyperthyroidism
 - Stimulant Disease
 - Cardiovascular Disease
 
 - Body Mass Index (BMI)
 - Auscultate Great Vessels for Arterial Bruits
 - Penile curvature
- Peyronie Disease
 - Ruptured corpora cavernosum
 - Venous leakage
 
 - Endocrine exam
- Thyroid Exam
 - Hypogonadism Signs
- Testicular atrophy
 - Gynecomastia
 
 
 - Neurologic function (Rectal Tone, Bulbocavernosus Reflex, perineal Sensation)
- Lumbar central spinal stenosis
 - Pelvic surgery
 - Pelvic Trauma
 
 - Prostate enlargement
 
VIII. Evaluation: Scales
- Depression Screening (e.g. PHQ-9)
 - International Index of Erectile Function Questionnaire (IIEF-5)
 
IX. Labs: Initial
- Fasting Serum Glucose (or Hemoglobin A1C)
 - Fasting Lipid profile
 - Morning Total Testosterone Level
- Indications: Hyogonadism signs (controversial)
- Small Testes
 - Lack of male secondary sex characteristics
 - Very low libido
 - Inadequate PDE-5 Inhibitor (e.g. Viagra) response
 - Indicated in most cases (especially men over age 50 years, and in signs of Hypogonadism)
 
 - Interpretation
- Total Testosterone <300 ng/ml suggests Hypogonadism
 - Confirm abnormal Serum Testosterone with repeat test in 2-3 months
- Consider free Testosterone Level if repeatedly normal, however levels are not standardized
 
 - Consider Testosterone Supplementation for persistently low Testosterone
 
 
 - Indications: Hyogonadism signs (controversial)
 - 
                          Thyroid Stimulating Hormone (TSH)
- Especially indicated in all older men
 
 
X. Labs: Endocrine as indicated
- Follicle Stimulating Hormone (FSH)
 - 
                          Luteinizing Hormone (LH) Indications
- Hypogonadism evaluation for low Testosterone
 
 - 
                          Prolactin Level Indications
- Suspected Prolactinoma
 - Serum Free Testosterone decreased
 - Libido decreased significantly
 
 
XI. Labs: Other tests if indicated
- Serum Chemistry Panel (Chem7)
 - Urinalysis
 - Complete Blood Count
 - Prostate Specific Antigen (PSA)
 
XII. Evaluation: Assessment of nighttime Erection
- Indication: Psychogenic cause suspected
 - Rarely performed now
 - Techniques
- Snap-gauge cuff
 - Rigiscan (Nocturnal penile tumescence monitoring)
 
 
XIII. Evaluation: Advanced Testing by Urology
- Biothesiometry
 - Penile-brachial index
 - Duplex Ultrasound (Color flow doppler)
 - Cavernosometry or Cavernosography
 - Arteriography
 - Psychological Testing
 
XIV. Management
XV. Precautions: Cardiovascular Risk
- Erectile Dysfunction is a Cardiovascular Risk
- Mortality Hazard Ratio: 2.04
 - Cardiovascular event Hazard Ratio: 1.62
 - More severe Erectile Dysfunction is associated with higher Cardiovascular Risk
 - Bohm (2010) Circulation 121:1375-1376 [PubMed]
 
 - Erectile Dysfunction may be comorbid with cardiovascular disease
 - Consider Cardiovascular Risk management
 
XVI. References
- Beaudreau (August, 2000) Federal Practitioner, p. 11-8
 - Ferris (1997) Fam Pract Recert 19(1):47-58
 - Napolatono (1998) Fam Pract Recert 20(11): 34-58
 - Dewire (1996) Am Fam Physician 53(6): 2101-6 [PubMed]
 - Greiner (1996) Am Fam Physician 54(5): 1675-82 [PubMed]
 - Guay (1995) Postgrad Med 97(4): 127-43 [PubMed]
 - Jordan (1999) Postgrad Med 105(2): 131-47 [PubMed]
 - Viera (1999) Am Fam Physician 60(4): 1159-66 [PubMed]
 - Heidelbaugh (2010) Am Fam Physician 81(3): 305-12 [PubMed]
 - McVary (2007) N Engl J Med 357(24): 2472-81 [PubMed]
 - Rew (2016) Am Fam Physician 94(10): 820-7 [PubMed]